KISA 2026 Contract Recruitment: Machine Equipment Maintenance Manager, Records Management Specialist

KISA (Korea Internet & Security Agency) has posted a first-round 2026 recruitment notice for two indefinite-term contract positions: a Machine Equipment Maintenance Manager and a Records Management Specialist. Applications must be submitted via the dedicated portal at kisa.applyin.co.kr, with supporting documentation including a job description form and KISA employee recruitment guide available as PDF attachments. The notice was published on 26 March 2026 and had been viewed 6,372 times at time of publication.

NIH-Funded AI Model Predicts Cancer Survival from Single-Cell Tumor Data

Researchers at Oregon Health & Science University (OHSU), supported by NIH's National Cancer Institute, developed scSurvival, a machine learning model that analyzes single-cell tumor data to predict patient survival outcomes. The model was validated on clinical data from more than 150 cancer patients with melanoma and liver cancer, demonstrating improved accuracy over traditional methods by identifying specific immune and tumor cell populations associated with treatment response and survival risk.

Dr. Jonathan M. Green Selected CEO of NIH Clinical Center

NIH has selected Dr. Jonathan M. Green as chief executive officer of the NIH Clinical Center, the world's largest hospital devoted to clinical research. Dr. Green will begin his role on May 17, 2026, overseeing the Clinical Center's nearly $700 million annual operating budget, its 200-bed, 870,000-square-foot research center on NIH's Bethesda campus, and an ongoing expansion adding over 570,000 square feet of space expected to be completed in 2029. The Clinical Center recorded over 3,000 inpatient admissions and nearly 72,000 outpatient visits last year, with every patient enrolled in a research protocol.

NIH-Funded CRISPR Breakthrough Enables Precision Delivery for Cancer, ALS

NIH-funded researchers at UT Austin discovered an enhanced CRISPR gene-editing system (Al3Cas12f) small enough for targeted delivery in the human body using adeno-associated virus vectors. The engineered variant (Al3Cas12f RKK) improved editing efficiency from less than 10% to more than 80%, potentially enabling treatments for cancer, ALS, and other diseases.

ART Issues Opinion on Paris Airports Economic Regulation Contract Draft 2027-2034

ART published avis n°2026-030 on April 9, 2026, delivering its simple opinion on the draft Economic Regulation Contract (CRE) between the French State and Aéroports de Paris for the period January 1, 2027 to December 31, 2034. The 8-year derogaotry contract supports an unprecedented €8.4 billion investment program with approximately €17 billion in forecast charges. The Authority makes four sets of recommendations: (1) revision and consolidation of economic/financial trajectories; (2) better alignment of risk and remuneration, with a maximum acceptable WACC of 5.6% after tax for the 8-year contract versus 4.3% under annual regulation; (3) improved tariff structure transparency and coherence; (4) strengthened contractual clarity and user information. This opinion is preparatory to the binding avis conforme the Authority must render on the final negotiated CRE, with implementation of recommendations deemed reasonable and proportionate to the announced January 1, 2027 effective date.

ART Publishes Highway Concession Market Reform Guidelines

ART has published two new guidelines on highway concession company (SCA) market commissions—one on commission composition and one on internal rules. The guidelines implement the reform from the March 18, 2026 decree, which significantly raised thresholds for adapted procedures, notably for works contracts between €500,000 and €2 million excluding VAT. Concessionary companies must submit their new internal rules to ART for approval by May 18, 2026, with the rules applicable to contracts where consultation begins from July 1, 2026 onward.

3rd Mobility Data Meetings Webinar, June 5, 2026

ART (Autorité de régulation des transports) announces the 3rd edition of its Mobility Data Meetings (Rencontres données de mobilité) on Friday, June 5, 2026, as a webinar from 9:45 to 16:00. Co-labeled NAPCORE, the event is chaired by Sophie Auconie, Vice-President of ART, and brings together public actors, experts, and European partners to share best practices on mobility data publication and traveller information. Sessions cover EU orientation and implementation, facilitated use of mobility data for travellers, concrete compliance levers, and technical arbitration related to data publication.

EP3542333A1 - Mobile Voice Data Services via Cryptocurrency, Eric Martin

The European Patent Office published EP3542333A1, a European patent application for a system and method enabling mobile voice, data, and text services to be delivered via cryptocurrency transactions. The patent application was filed by Eric Martin and covers IPC classifications G06Q including payment systems, commerce platforms, and data services. The publication date is April 15, 2026.

Cardless ATM Transaction via Mobile Device System

Mastercard International Incorporated has obtained publication of European patent application EP3507754A1 for a method and system enabling cardless ATM transactions via mobile devices. The application, filed with the European Patent Office, names Daniel Jason Goodman, Max Alexander Belin, and Michael Leung as inventors, with the publication date of April 15, 2026. The invention covers a mobile-based authentication system for cash withdrawal without physical payment cards.

NChain Blockchain Random Number Generation Patent, Apr 15

European Patent Application EP3669314A1 filed by nChain Licensing AG for blockchain-based random number generation was published by the EPO on 15 April 2026. The application names inventors CHAN Ying, KRAMER Dean, and WRIGHT Craig Steven and is classified under IPC categories G06Q 20/22, G06Q 20/38, and H04L 9/08. The application is designated for all contracting states including AT, BE, CH, DE, DK, ES, FI, FR, GB, IE, IT, NL, NO, PT, SE, and others.

Tradeweb Markets LLC European Patent EP3633584A1 Financial Transaction Clearing System

European Patent application EP3633584A1 titled 'SYSTEM AND METHOD FOR CLEARING TRANSACTIONS' was published by the EPO on April 15, 2026. The patent application was filed by Tradeweb Markets LLC with inventors Elisabeth Kirby, Kevin Hill, and Ian Stocks. The invention covers financial transaction clearing systems classified under IPC G06Q 40/00 (finance; insurance; commerce; administration; commercial or business management) and is designated across 32 EU member and extension states.

Methods and Systems for Continuous Risk Monitoring and Dynamic Underwriting Pricing, Virtual I Switzerland Ltd.

The EPO published patent application EP3655910A1 for 'Methods and Systems for Continuous Risk Monitoring and Dynamic Underwriting Pricing' filed by Virtual I Switzerland Ltd., with inventor Geylani Veysel Sinan, published April 15, 2026. This publication establishes a priority date and makes the technical details publicly available, indicating the applicant's intent to seek exclusive rights across EPO member states. The patent application covers continuous risk monitoring and dynamic underwriting pricing systems with applications in insurance, financial services, and potentially other sectors.

Ant Group Blockchain Transaction Method EP Patent Published

The EPO published patent application EP2024001024A1 filed by Ant Blockchain Technology (Shanghai) Co., Ltd. on April 15, 2026, covering a method for executing transactions in a blockchain system. The application is classified under G06Q 40/04 (financial transaction systems) and the designation of inventor has not yet been filed. The application covers designated EPO contracting states including DE, FR, GB, IT, NL, and 26 other jurisdictions.

Royal Bank of Canada Digital Reward Processing Patent

Royal Bank of Canada has obtained publication of European patent application EP4254220A2, titled 'Methods and Systems for Digital Reward Processing', published by the EPO on 15 April 2026. The application lists inventors Edison U. Ortiz and Iustina-Miruna Vintila and covers digital reward processing systems incorporating cryptographic and privacy-enhancing technologies. The application is published for all 38 designated contracting and extension states across Europe.

METHOD AND SYSTEM FOR ATTRIBUTING A TRANSACTION PARAMETER

The EPO published patent application EP2024112256A1 by applicant Tenpay Global Pte. Ltd. on April 15, 2026, covering methods and systems for attributing a transaction parameter. The invention relates to financial technology under IPC classifications G06Q 40/04 and G06Q 30/0601, with all EU member states designated as potential validation states.

Dutch North Sea Programme 2028-2033 Cross-Border Participation Notice Under Espoo Convention

BSH published a notice on 13 April 2026 initiating Germany's cross-border participation in the Dutch North Sea Programme 2028-2033 scoping process, pursuant to Article 10 of the Espoo Convention on Environmental Impact Assessment in a Transboundary Context. Scoping documents and participation plans are available on the BSH website from 13 April through 11 May 2026, with physical copies accessible at BSH libraries in Hamburg and Rostock during business hours. Comments on the scoping documents must be submitted to the Dutch Ministry for Infrastructure and Water Management by 11 May 2026, or alternatively to BSH by 8 May 2026.

BSH 2025 Annual Report Released, Digital Navigation Focus

BSH has released its 2025 Annual Report, highlighting the official beginning of the IHO S-100 standard implementation for digital nautical charts in early 2026, which the agency describes as revolutionising maritime navigation. The report also commemorates BSH's 35th anniversary on 3 October, marking 35 years of German unity with a celebratory event including an open day and ship tours. Additional topics covered include the MoBo monitoring buoy deployed in the North Sea from September 2025, sea surface temperatures in the North and Baltic Seas, and offshore wind energy developments.

Germany BSH Annual Press Conference 2026: Offshore Wind, Maritime Navigation, and Safety

Germany's BSH held its 2026 annual press conference highlighting offshore wind expansion targets of 10.2 GW currently installed, with a 40 GW interim target for 2035 (projected to be reached in 2034 with ~42 GW) and 70 GW by 2045. A Denmark-Germany agreement for 2 GW of cross-border offshore wind was signed at the January 2026 North Sea Summit. The IMO MASS-Code for autonomous vessels is planned for adoption in May 2026. BSH also reported increasing satellite navigation disruptions in the Baltic Sea and provided an update on the OceanEye initiative (€50M for global ocean observation) and Germany's participation in the Argo program (funding 300 of 4,000 global floats).

Critical Spring Security Vulnerabilities Fixed, Authentication Bypass Risk

CSIRT-ITA issued an alert (AL05/260422/CSIRT-ITA) reporting that security updates have resolved new vulnerabilities in Spring Security and Spring Authorization Server, including one classified as "critical" severity and two classified as "high" severity. The affected products include Spring Security versions 7.0.4 and earlier, and Spring Authorization Server versions 1.3.10, 1.4.9, 1.5.6 and earlier. Three CVEs are referenced: CVE-2026-22752, CVE-2026-22753, and CVE-2026-22754. The alert recommends updating vulnerable products to patched versions following the vendor security bulletins published at spring.io/security.

Zimbra CVE-2025-48700 Active Exploitation Detected by Italy CSIRT

CSIRT-ITA has issued Alert AL06/260422/CSIRT-ITA confirming active in-the-wild exploitation of CVE-2025-48700, a stored Cross-Site Scripting vulnerability in Zimbra Collaboration Suite with CVSS v3.x score of 7.2 (High). The flaw stems from insufficient HTML sanitization in the Classic UI email interface, allowing malicious code hidden in HTML email content to bypass security controls and execute in users' browser sessions, enabling unauthorized access to sensitive system information. Affected versions span ZCS 10.1.x, 10.0.x, 9.x, and 8.8.x branches prior to their respective latest patched releases. CSIRT-ITA recommends immediate patching to the latest available versions as the primary mitigation measure.

Ball Lock Assembly Retention Pin EP3880279A1

The European Patent Office granted European patent application EP3880279A1 to Pulse NeedleFree Systems, LLC for a ball lock assembly with retention pin used in medical injection devices. The patent, filed by inventor Mikhail Zolotukhin, covers A61M 5/48 and A61M 5/315 classifications and is designated valid in 31 European member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.

Lymphatic System Drug Delivery Patent EP3801464A1

The European Patent Office published patent application EP3801464A1 titled 'Drug Delivery Methods Targeting the Lymphatic System' on April 15, 2026. The patent applicant is Vivasor, Inc., with inventor Russell Frederick ROS, and covers IPC classifications A61K 9/00, A61M 37/00, A61P 35/00, and A61P 35/04. The designated states include all EPC contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Guide Extension Catheter EP3908197A1, Teleflex, Apr 15

The European Patent Office granted patent EP3908197A1 to Teleflex Life Sciences LLC on April 15, 2026, for a guide extension catheter. The patent lists Joshua Brenizer, Dean Peterson, Thomas Kouchoukos, and Mark Wendle as inventors, with IPC classifications covering catheter and valve devices. The patent confers exclusive rights to Teleflex for the stated term from filing.

Methods for Promoting Hair Growth - EP3801734A1

The European Patent Office granted patent EP3801734A1 to Follica, Inc. on April 15, 2026, titled 'Methods for Promoting Hair Growth.' The patent application covers hair growth promotion methods under IPC classifications A61M 37/00, A61P 17/14, and A61Q 7/02. The designated states include all EU member states plus associated countries (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

EP3928814A1 Wearable Drug Delivery Device, Apr 15, 2026

The European Patent Office published application EP3928814A1 on April 15, 2026, covering a wearable drug delivery device filed by mylife Diabetes Care AG. The application carries IPC classifications A61M 5/142 and A61M 5/158 and designates 31 contracting states including Germany, France, the United Kingdom, Italy, Spain, and other EU member states. Six inventors are credited: Baumert, Jan, Hanimann, Michael, Margot, Roland, Streit, Ursina, Bosshard, Simon, and Steiner, Fabian.

Drug Depot Delivery System for Image-Guided Targeting, Murphy

The EPO published patent application EP3752239A1 for a drug depot delivery system designed for image-guided targeting to a target site. The application names Murphy, Kieran P. as both applicant and inventor under IPC classifications A61M (medical preparations delivery devices) and A61B (diagnostic instruments). The patent designates all EU member states plus associated countries as covered territories.

Adjustable Curved Sheath Tube And Stent Delivery Device

The European Patent Office has published patent EP3903742A1 for an adjustable curved sheath tube and stent delivery device, filed by Hangzhou Endonom Medtech Co., Ltd (inventors: WANG, Yongsheng; LI, Jianmin). The patent, classified under A61F 2/95 and A61M 25/092, covers a medical device designed to facilitate curved sheath tube adjustment during stent delivery procedures. The publication grants EPO intellectual property rights across 31 designated contracting and extension states.

PIERCING DEVICE FOR AN ADMINISTRATION DEVICE EP3863698A1 mylife Diabetes Care

The European Patent Office published patent application EP3863698A1 titled 'Piercing Device for an Administration Device' on April 15, 2026. The patent was filed by mylife Diabetes Care AG with inventors STREIT, Ursina, HOSTETTLER, Patrick, HOFER, Christophe, and MARGOT, Roland. The invention relates to A61M medical devices and is designated for all EU member states plus other EPC contracting states.

Ventec Life Systems EP3976229A1 Medical Gas Concentrator, Apr 15

EPO published European Patent Application EP3976229A1 on April 15, 2026, filed by Ventec Life Systems, Inc. The patent covers a system and method for concentrating medical gas. Named inventors are Haneh Y. Yehya, Alex P. Valentine, and Michael J. Budinger. The application designates all EU member states plus Switzerland, Norway, Turkey, and other European countries.

Fresenius Medical Care Accuracy Checking Method

The European Patent Office published patent application EP3914314A1 by Fresenius Medical Care Deutschland GmbH on April 15, 2026, covering a method and device for checking the accuracy of conveying means in medical treatment devices. The application lists inventor Joachim Noack with IPC classifications A61M 1/16 and A61M 1/34. The designated states cover major European markets including Germany, France, the United Kingdom, Italy, and Spain.

Ejection Device for Syringes EP3721923A1

The European Patent Office published patent application EP3721923A1 titled 'Ejection Device for Syringes', filed by applicant and inventor Heiden, Klemens. The application covers medical device technology classified under IPC subclass A61M, specifically relating to syringe ejection and dosage mechanisms. The publication designates 35 contracting states across Europe.

European Patent, Blood Flow Regulation, LivaNova, 15th Apr

The European Patent Office published application EP4132605A1 for LivaNova Deutschland GmbH, covering a method and system for regulating blood flow in extracorporeal circulation. The application was published April 15, 2026, with inventors Penka and Schubert listed, and classified under A61M 1/36 and related A61M 60/ categories. The patent designates all contracting states including DE, FR, GB, NL, IT, ES, and 25 other European jurisdictions.

Ruim 2 Miljoen Bezoeken aan Kwaadaardige Websites Voorkomen in Anti-Phishing Pilot

Het Anti Phishing Shield, een publiek-private samenwerking tussen het ministerie van Justitie en Veiligheid, NCSC, KPN, de politie, de Nederlandse Vereniging van Banken en NLconnect, heeft sinds de start van de pilot in juli 2025 ruim twee miljoen pogingen om phishing- en frauduleuze websites te bezoeken geblokkeerd onder ruim 200.000 gebruikers. Het NCSC verzamelt continu actuele informatie over malafide domeinen via publieke en commerciële bronnen en deelt deze via een DNS-service met deelnemende internetaanbieders; de denial list wordt elk kwartier geactualiseerd en bevat inmiddels ruim 160.000 kwaadaardige domeinen. Door het succes van de pilot wordt het Anti Phishing Shield bij het NCSC ondergebracht en wordt onderzocht hoe het bereik en de effectiviteit verder vergroot kunnen worden.

Tweede Kamer Approves Cyberbeveiligingswet, NIS2 Implementation

On April 15, 2026, the Dutch House of Representatives (Tweede Kamer) approved the Cyberbeveiligingswet (Cbw) and the Wet weerbaarheid kritieke entiteiten, implementing the EU NIS2 directive into Dutch law and replacing the current Wbni. The law establishes duty-of-care, reporting, and registration obligations for approximately 8,000 organizations under NCSC responsibility. The bills now proceed to the Eerste Kamer (Senate) for further consideration, with planned implementation in Q2 2026.

Anthropic's Frontiermodel Mythos Vraagt Om Directe Actie

NCSC-NL issued an advisory on April 15, 2026 warning that Anthropic's new AI model Mythos — capable of vulnerability detection and exploit chaining — poses increased cyber threat risks. The agency urges organizations to accelerate patch processes, reduce time-to-patch from days/weeks to hours, and integrate AI developments into security measures. Reaction cycles previously measured in days will shrink to hours as both defenders and attackers leverage AI capabilities.

PRAC Warns of Ixchiq Vaccine Aseptic Meningitis Risk in Healthy Young Adults

PRAC completed its review of a safety signal of aseptic meningitis with Ixchiq (live attenuated chikungunya vaccine) and recommended updating the product information to reflect that serious side effects such as aseptic meningitis have also been observed in healthy young adults. Previously, most reported cases had occurred in older people (over 65 years of age) or those with multiple long-term conditions. PRAC is also conducting a periodic safety update report assessment concluding in June 2026.

Fibclot 1.5g Unavailable Until Jan 2027, 25% Consumption Reduction Required

The FAMHP task force Unavailability has issued recommendations due to the temporary unavailability of Fibclot 1.5g from 9 October 2025 until 31 January 2027. All Belgian hospitals are requested to reduce overall human fibrinogen consumption by at least 25% to ensure continued treatment for highest-priority patients. Alternative products Fibryga 1g and Riastap 1g remain available but cannot fully meet expected needs.

EU Article 10a MDR/IVDR Decision Tree for Marketing Interruption Notification

The European Commission published a decision tree to guide economic operators—including manufacturers and agents—on applying Article 10a of EU Regulations 2017/745 (MDR) and 2017/746 (IVDR). The tool clarifies when ending or interruption of medical device or in vitro diagnostic marketing requires notification to FAMHP. Economic operators should use this decision tree to determine their reporting obligations before notifying the Belgian authority.

Contactless Card Payments Reached 83% of Total Estonia

Eesti Pank published its monthly statistical release reporting that contactless card payments accounted for 83% of total card payments in Estonia. The release covers payment statistics including payments sent and received, card payments, and payees by main economic activity. The statistical release is explicitly noted to be independent of economic policy and presented separately from policy releases. A separate quarterly statistical release for Q2 2026 is scheduled for 23 July 2026.

Hawaii PUC Opens VPP Docket for Grid Integration

The Hawaii Public Utilities Commission has opened Docket No. 2026-0084 to design a Virtual Power Plant (VPP) grid-services program that will better integrate customer-sited energy resources such as rooftop solar and battery storage to support grid operations across Hawaiian Electric service territories. The commission found that while Hawaii has high distributed energy resource adoption, many resources are not optimized for grid reliability or fossil fuel reduction. The proceeding will explore remote-dispatch models, performance-based compensation, and expanded access including low- and moderate-income households. Individuals and organizations may file a motion to intervene or participate within 20 days.

Montana Unemployment Rate Remains at 3.6% in February 2026

Montana's seasonally adjusted unemployment rate remained unchanged at 3.6% in February 2026, while the national unemployment rate rose to 4.4%. The state's labor force declined month-over-month but has grown by nearly 3,000 workers over the past twelve months. Payroll jobs declined by 500 positions, with leisure and hospitality losses partially offset by construction gains. The Consumer Price Index rose 0.3% in February, with the all-items index up 2.4% year-over-year.

Mississippi Ranks 29th Nationally, Meets All 10 NIEER Pre-K Quality Benchmarks

The Mississippi Department of Education announced that Mississippi now ranks 29th in the nation for preschool enrollment of 4-year-olds, up from 31st, based on NIEER's 2025 State of Preschool Yearbook. Mississippi is one of only six states to meet all 10 of NIEER's recommended benchmarks for preschool quality, which measure teacher qualifications, class sizes, early learning standards, and program assessments. In the 2024-2025 school year, Mississippi's state-funded pre-K programs enrolled 8,076 children, an increase of 931 from the prior year, with state spending totaling $39,017,901, up 20% adjusted for inflation.

Albania Unveils Green Taxonomy Draft with EU Support

The Bank of Albania, in cooperation with the European Investment Bank (EIB), presented the first draft of Albania's Green Taxonomy at a technical workshop on April 22, 2026. The taxonomy aims to increase transparency in the financial market, direct capital toward sustainable development activities, and strengthen long-term financial stability. The workshop gathered representatives from multiple ministries, the financial sector, business community, and environmental organizations to provide consultative comments. The process is expected to culminate in a Memorandum of Understanding formalizing inter-institutional cooperation, and aligns with Albania's EU integration requirements.

Long-Term Adherence Study of PCSK9 Inhibitors (Inclisiran, Evolocumab, Alirocumab)

ClinicalTrials.gov registered observational study NCT07543731 on April 22, 2026, evaluating long-term adherence and persistence to three PCSK9 inhibitors—inclisiran, evolocumab, and alirocumab—in real-world clinical practice. The study focuses on patients with familial hypercholesterolemia and atherosclerotic cardiovascular disease. This is an informational registry entry with no compliance obligations imposed.

Study on VR-relaxation for ECT-related Anxiety, NCT07546526

A new clinical trial registration on ClinicalTrials.gov (NCT07546526) studying whether Virtual Reality (VR)-based relaxation reduces anxiety in patients receiving electroconvulsive therapy (ECT) as part of routine clinical care. Researchers will compare VR-relaxation, breathing exercises, and treatment as usual as interventions, measuring ECT-related anxiety, stress symptoms, and heart rate as outcomes.

MBSR Combined With Aerobic Training for Post-PCI Recovery

A randomized controlled trial (NCT07544459) registered on ClinicalTrials.gov will evaluate mindfulness-based stress reduction (MBSR) combined with aerobic training versus aerobic training alone in 150 post-PCI coronary heart disease patients. The dual-intervention approach targets treatment adherence, kinesiophobia, heart rate variability, exercise tolerance, and psychological stress responses, with assessments using standardized scales including the TSK-SV Heart, SAS, and SDS. Results will inform cardiac rehabilitation practice, though no compliance obligations arise from this trial registration alone.

Observational Study on Quran Recital Effects in MS Patients

An observational clinical trial has been registered on ClinicalTrials.gov under NCT07544303 to evaluate the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis. The study will call patients to assess continued Quran recital practice, with the control group continuing routine treatment and no additional intervention. Final measurements will be conducted in-person at the hospital at the end of week four. The estimated study completion date is April 22, 2026.

AI-based Predictive System for Detecting Lymphoma Patient Non-compliance With Oral Therapies

ClinicalTrials.gov registry entry NCT07546188 documents an observational study assessing an AI-based system for predicting patient non-compliance with oral therapies in lymphoma patients. The study, registered as observational with retrospective and prospective patient groups, focuses on Non-Hodgkin lymphoma and care coordination. The research aims to enhance the responsiveness and accuracy of clinical interventions through artificial intelligence.

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NIH ClinicalTrials.gov registered study NCT07545473 investigating hyperspectral retinal imaging as a non-invasive method for detecting retinal amyloid beta in Alzheimer's disease and other neurodegenerative conditions. The study will enroll participants with or at risk of dementia, including Alzheimer's disease, Parkinson's disease, Lewy-Body dementia, vascular dementia, frontotemporal dementia, and Niemann-Pick diseases. The intervention involves use of a hyperspectral camera to capture retinal image data across multiple wavelengths.

AIManage Using an AI-driven CDS and Chatbot

NIH registered Clinical Trial NCT07546357 for AIManage, a GenAI-powered Clinical Decision Support tool designed to assist with incretin mimetic medication management and dose titration optimization. The study is being conducted across primary care and obesity medicine clinics at NYUH and is currently in Phase 1 (formative data collection for tool refinement), with a cluster randomized controlled trial planned for Phase 2. Conditions studied include Diabetes, Obesity, and Medication Side Effects.